Presentation is loading. Please wait.

Presentation is loading. Please wait.

CS-100 CS Marketing Group, LLC.

Similar presentations


Presentation on theme: "CS-100 CS Marketing Group, LLC."— Presentation transcript:

1 CS-100 CS Marketing Group, LLC

2 Copyright, Trigon Medical Devices Inc. 2011
CS-100 (Cardio Scan 100) An Acquisition and FCG (Frequency Cardiograph) Spectrum Diagnostic System A Preliminary Screening Tool To Detect Coronary Artery Diseases (CAD) Early Ischemia to Myocardial Infarction presentation 4/6/2017 Copyright, Trigon Medical Devices Inc. 2011

3 Copyright, Trigon Medical Devices Inc. 2011
Cardiovascular Disease The #1 killer and cause of disability in the world - 1 million deaths in the U.S. and 17 million worldwide every year. - Debilitates more than 5 million every year. Approximately 23% of myocardial infarctions go undetected. - #1 cause of sudden death - Irreversible debilitating condition Over $30 billion in payments were made to Medicare beneficiaries for hospital expenses. CS-100 meets the need for a risk free and cost effective screening tool to detect ischemic heart diseases in its early stage. - Preventive screening tool for primary care physicians - Detect ischemic condition that is reversible by exercise and dietary change 4/6/2017 Copyright, Trigon Medical Devices Inc. 2011

4 Copyright, Trigon Medical Devices Inc. 2011
CS-100 RESEARCH AND DEVELOPMENT A Different Approach More than 30 years research and development. Heart is a dual functioning machine – electric generator and pump. Change in heart’s physiology will cause change in EKG waveform. Apply Digital Signal Processing Principles in digitizing and transforming 12 lead ECG into frequency components of energy value (uV) at frequency (Hz). - Use differential diagnosis to identify and select diagnostic indexes. Statistically compare the value of each index against the value from the data base to determine abnormal (+) or normal (-) for each diagnostic index. From (+) indexes to detect ischemic condition from early ischemia to myocardial infarction. 4/6/2017 Copyright, Trigon Medical Devices Inc. 2011

5 Copyright, Trigon Medical Devices Inc. 2011
Schematic Flow Chart of CS-100 Electrodes Time Domain Cardiac Electrical Currents ECG Electrocardiogram Complied and Recorded FFT (Fast Fourier Transformation) Into Frequency Components Digital Signal Analysis (1) Power Spectrum (2) Phase Shift (3) Impulse Response FCG Frequency Cardiograph and Diagnostic Indexes Index Value - Data Base (30,000 tests) 4/6/2017 Copyright, Trigon Medical Devices Inc. 2011

6 COMPARISON OF TESTS TO DIAGNOSE HEART DISEASES
Test Average Test Risk Time Cost/Test Accuracy Limitation Stress Test Moderate min $ % High false reading for abnormal ECG Chemical Moderate hours $3, % Higher false positive if Stress Test hypertensive Angiogram High hours $10, % Highly invasive, expensive CS None min $2, % Accuracy is similar to heart catheterization, non invasive. * The expensive and non-routinely used Ultra-Fast CT Scan & PET technology are not included for comparison. 4/6/2017 Copyright, Trigon Medical Devices Inc. 2011

7 Copyright, Trigon Medical Devices Inc. 2011
CS - 100 ADVANTAGES & BENEFITS - Non-Invasive (No Injection or catheters required) - No Strenuous Exercise Required (Patient is at rest) Safe and Easy to Operate On-site Diagnosis for CAD in 12 minutes High Sensitivity High Specificity Limited Training Required Cost Efficient 4/6/2017 Copyright, Trigon Medical Devices Inc. 2011

8 Copyright, Trigon Medical Devices Inc. 2011
What the Experts Say: “This technology (cardio spectrum diagnostic system) is a signature new method of early Screening for heart diseases. It is --- a very simple, fast, and non-invasive method and should be used in clinics where cardiac screening is performed, as well as by primary care physicians.” William J. Tenet, M.D., New York Hospital – Medical Center of Queens “This technology (cardio spectrum diagnostic system) will provide a significant new method of early diagnosis of heart diseases.” Marne Def. Gomes, M.D., Dean of Institute of Cardiology, Foundation University of Cardiology – Brazil “Frequency Domain FCG may index LVH with a high accuracy and the prediction of MID is largely superior (based on F statistics) to standard time-domain ECG parameters, either taking voltage alone or time-voltage integral into consideration. It may thus be a new tool to help indexing the probabilistic presentation of LVH.” Paolo Emilio Puddu, Institute of Heart and Great Vessels, Ls Sapienza University, Rome, Italy 4/6/2017 Copyright, Trigon Medical Devices Inc. 2011

9 Copyright, Trigon Medical Devices Inc. 2011
CS – 100 Opening Page FCG Spectrum Analysis 4/6/2017 Copyright, Trigon Medical Devices Inc. 2011

10 Copyright, Trigon Medical Devices Inc. 2011
CS-100 Important Features This device complies with the accepted specifications to provide the maximum safety to patients and operators. A Window based touch screen diagnostic system with an easy to operate menu. Acquire 10 leads ECG signal simultaneously and continuously for up to one hundred and ten seconds. Two ECG time-domain waveform display (6x2 and 12x1). Frequency Analysis with CS-100 spectrum displays. Five power spectrum diagnostic indexes for each of the 12 leads. - Five special diagnostic indexes for Lead II and V5. 4/6/2017 Copyright, Trigon Medical Devices Inc. 2011

11 Copyright, Trigon Medical Devices Inc. 2011
ECG (Electrocardiograph) CS-100 has the ECG data acquisition capability to acquire and record a conventional 12 lead ECG simultaneously; and to display and print out the ECG graph in two different formats: 12x1 and 6x2 12x1 ECG Wave Display 4/6/2017 Copyright, Trigon Medical Devices Inc. 2011

12 Copyright, Trigon Medical Devices Inc. 2011
- Also can display and print out a 6 x 2 ECG 6 x 2 ECG Wave Display 4/6/2017 Copyright, Trigon Medical Devices Inc. 2011

13 Copyright, Trigon Medical Devices Inc. 2011
FCG (Frequency Cardiogram) Unique and Valuable System - An Innovative and scientifically proven system. - High degree of sensitivity and accuracy. - Cardiac screening for early diagnosis of heart disease. - Preventive warning for reversible ischemia. - Detection of ischemic myocardium injuries which may eventually lead to more serious heart problems. 4/6/2017 Copyright, Trigon Medical Devices Inc. 2011

14 Copyright, Trigon Medical Devices Inc. 2011
FCG (Frequency Cardiogram) Advanced Technology - Automatically amplify, filter and digitize the 12 lead cardio-electrical signals; - Transform those digitized signals into 12 individual frequency domain spectra; - Calculate and Determine (+) or (-) for each diagnostic index; - Frequency range from 0 Hz to 25.6 Hz with much refine 0.2 Hz resolution Display and Print-out one page of power spectra with 60 diagnostic indexes (one power spectrum with 5 indexes for each of the 12 lead); - a multi-color CAD location picture, and frequency graph for power spectrum, phase angle shift and impulse response and their respective diagnostic indexes for lead II and V. 4/6/2017 Copyright, Trigon Medical Devices Inc. 2011

15 Copyright, Trigon Medical Devices Inc. 2011
FCG Power Spectrum - CS-100 displays and prints out a power spectrum with all 12 leads on one page; - Each power spectrum lists five (5) ischemic diagnostic indexes 12-Lead FCG Power Spectra with Ischemic Diagnostic Indexes 4/6/2017 Copyright, Trigon Medical Devices Inc. 2011

16 Copyright, Trigon Medical Devices Inc. 2011
12 LEAD POWER SPECTRUM can detect - Insufficient myocardial energy caused by lack of blood supply (Early Ischemia) - Myocardium injuries - Ventricular hypertrophy or Ischemic Cardiomyopathy - Myocardial Ischemia - Myocardial compensation has set in for one or more years - CAD and its location 4/6/2017 Copyright, Trigon Medical Devices Inc. 2011

17 Copyright, Trigon Medical Devices Inc. 2011
Two Lead Analysis: analyze the digitized data from the two leads (V5 and II) to determine the (+) or (-) for one diagnostic index designated for phase shift and five (5) indexes for impulse response; and Display and print out a two-lead frequency graph showing two power spectra (one for lead II and one for lead V5, one phase shift and one impulse response. FCG Power Spectra for Lead II and Lead V5, and Their Phase Shift and Impulse Response 4/6/2017 Copyright, Trigon Medical Devices Inc. 2011

18 Copyright, Trigon Medical Devices Inc. 2011
Two Lead Analysis can detect: - Poor blood flow to the heart, poor blood circulation and change of blood dynamics. - Poor or defective conduction function, unstable cardiac electricity. - Left bundle branch conduction block. - CAD , coronary artery blockage, or myocardial infarction (MI). - Unstable latent cardiac electrical activities at the beginning of contraction. 4/6/2017 Copyright, Trigon Medical Devices Inc. 2011

19 For More Information Contact:
CS Marketing Group, LLC 4/6/2017 Copyright, Trigon Medical Devices Inc. 2011 19


Download ppt "CS-100 CS Marketing Group, LLC."

Similar presentations


Ads by Google